238 related articles for article (PubMed ID: 26341558)
1. Foxa2 and Cdx2 cooperate with Nkx2-1 to inhibit lung adenocarcinoma metastasis.
Li CM; Gocheva V; Oudin MJ; Bhutkar A; Wang SY; Date SR; Ng SR; Whittaker CA; Bronson RT; Snyder EL; Gertler FB; Jacks T
Genes Dev; 2015 Sep; 29(17):1850-62. PubMed ID: 26341558
[TBL] [Abstract][Full Text] [Related]
2. Suppression of lung adenocarcinoma progression by Nkx2-1.
Winslow MM; Dayton TL; Verhaak RG; Kim-Kiselak C; Snyder EL; Feldser DM; Hubbard DD; DuPage MJ; Whittaker CA; Hoersch S; Yoon S; Crowley D; Bronson RT; Chiang DY; Meyerson M; Jacks T
Nature; 2011 May; 473(7345):101-4. PubMed ID: 21471965
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine differentiation in the 12T-10 transgenic prostate mouse model mimics endocrine differentiation of pancreatic beta cells.
Gupta A; Wang Y; Browne C; Kim S; Case T; Paul M; Wills ML; Matusik RJ
Prostate; 2008 Jan; 68(1):50-60. PubMed ID: 18004726
[TBL] [Abstract][Full Text] [Related]
4. Differential Tks5 isoform expression contributes to metastatic invasion of lung adenocarcinoma.
Li CM; Chen G; Dayton TL; Kim-Kiselak C; Hoersch S; Whittaker CA; Bronson RT; Beer DG; Winslow MM; Jacks T
Genes Dev; 2013 Jul; 27(14):1557-67. PubMed ID: 23873940
[TBL] [Abstract][Full Text] [Related]
5. FoxA1 and FoxA2 drive gastric differentiation and suppress squamous identity in NKX2-1-negative lung cancer.
Camolotto SA; Pattabiraman S; Mosbruger TL; Jones A; Belova VK; Orstad G; Streiff M; Salmond L; Stubben C; Kaestner KH; Snyder EL
Elife; 2018 Nov; 7():. PubMed ID: 30475207
[TBL] [Abstract][Full Text] [Related]
6. Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma.
Snyder EL; Watanabe H; Magendantz M; Hoersch S; Chen TA; Wang DG; Crowley D; Whittaker CA; Meyerson M; Kimura S; Jacks T
Mol Cell; 2013 Apr; 50(2):185-99. PubMed ID: 23523371
[TBL] [Abstract][Full Text] [Related]
7. LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas.
Tsai LH; Chen PM; Cheng YW; Chen CY; Sheu GT; Wu TC; Lee H
Oncogene; 2014 Jul; 33(29):3851-60. PubMed ID: 23995788
[TBL] [Abstract][Full Text] [Related]
8. Occludin is a direct target of thyroid transcription factor-1 (TTF-1/NKX2-1).
Runkle EA; Rice SJ; Qi J; Masser D; Antonetti DA; Winslow MM; Mu D
J Biol Chem; 2012 Aug; 287(34):28790-801. PubMed ID: 22761434
[TBL] [Abstract][Full Text] [Related]
9. Obligate progression precedes lung adenocarcinoma dissemination.
Caswell DR; Chuang CH; Yang D; Chiou SH; Cheemalavagu S; Kim-Kiselak C; Connolly A; Winslow MM
Cancer Discov; 2014 Jul; 4(7):781-9. PubMed ID: 24740995
[TBL] [Abstract][Full Text] [Related]
10. NKX2-1-mediated p53 expression modulates lung adenocarcinoma progression via modulating IKKβ/NF-κB activation.
Chen PM; Wu TC; Cheng YW; Chen CY; Lee H
Oncotarget; 2015 Jun; 6(16):14274-89. PubMed ID: 25881545
[TBL] [Abstract][Full Text] [Related]
11. Integrated cistromic and expression analysis of amplified NKX2-1 in lung adenocarcinoma identifies LMO3 as a functional transcriptional target.
Watanabe H; Francis JM; Woo MS; Etemad B; Lin W; Fries DF; Peng S; Snyder EL; Tata PR; Izzo F; Schinzel AC; Cho J; Hammerman PS; Verhaak RG; Hahn WC; Rajagopal J; Jacks T; Meyerson M
Genes Dev; 2013 Jan; 27(2):197-210. PubMed ID: 23322301
[TBL] [Abstract][Full Text] [Related]
12. Study of FoxA pioneer factor at silent genes reveals Rfx-repressed enhancer at Cdx2 and a potential indicator of esophageal adenocarcinoma development.
Watts JA; Zhang C; Klein-Szanto AJ; Kormish JD; Fu J; Zhang MQ; Zaret KS
PLoS Genet; 2011 Sep; 7(9):e1002277. PubMed ID: 21935353
[TBL] [Abstract][Full Text] [Related]
13. The ratio of FoxA1 to FoxA2 in lung adenocarcinoma is regulated by LncRNA HOTAIR and chromatin remodeling factor LSH.
Wang R; Shi Y; Chen L; Jiang Y; Mao C; Yan B; Liu S; Shan B; Tao Y; Wang X
Sci Rep; 2015 Dec; 5():17826. PubMed ID: 26658322
[TBL] [Abstract][Full Text] [Related]
14. NKX2-1/TTF-1: an enigmatic oncogene that functions as a double-edged sword for cancer cell survival and progression.
Yamaguchi T; Hosono Y; Yanagisawa K; Takahashi T
Cancer Cell; 2013 Jun; 23(6):718-23. PubMed ID: 23763999
[TBL] [Abstract][Full Text] [Related]
15. FoxA1 and FoxA2 control growth and cellular identity in NKX2-1-positive lung adenocarcinoma.
Orstad G; Fort G; Parnell TJ; Jones A; Stubben C; Lohman B; Gillis KL; Orellana W; Tariq R; Klingbeil O; Kaestner K; Vakoc CR; Spike BT; Snyder EL
Dev Cell; 2022 Aug; 57(15):1866-1882.e10. PubMed ID: 35835117
[TBL] [Abstract][Full Text] [Related]
16. FOXA2 attenuates the epithelial to mesenchymal transition by regulating the transcription of E-cadherin and ZEB2 in human breast cancer.
Zhang Z; Yang C; Gao W; Chen T; Qian T; Hu J; Tan Y
Cancer Lett; 2015 Jun; 361(2):240-50. PubMed ID: 25779673
[TBL] [Abstract][Full Text] [Related]
17. Tumor Suppressor Activity of Selenbp1, a Direct Nkx2-1 Target, in Lung Adenocarcinoma.
Caswell DR; Chuang CH; Ma RK; Winters IP; Snyder EL; Winslow MM
Mol Cancer Res; 2018 Nov; 16(11):1737-1749. PubMed ID: 30002193
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-inducible factor-1alpha modulates the down-regulation of the homeodomain protein CDX2 in colorectal cancer.
Zheng J; Sun X; Wang W; Lu S
Oncol Rep; 2010 Jul; 24(1):97-104. PubMed ID: 20514449
[TBL] [Abstract][Full Text] [Related]
19. KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.
Hwang DH; Sholl LM; Rojas-Rudilla V; Hall DL; Shivdasani P; Garcia EP; MacConaill LE; Vivero M; Hornick JL; Kuo FC; Lindeman NI; Dong F
J Thorac Oncol; 2016 Apr; 11(4):496-503. PubMed ID: 26829311
[TBL] [Abstract][Full Text] [Related]
20. Homeobox Transcription Factor NKX2-1 Promotes
Harada M; Sakai S; Ohhata T; Kitagawa K; Mikamo M; Nishimoto K; Uchida C; Niida H; Kotake Y; Sugimura H; Suda T; Kitagawa M
Mol Cancer Res; 2017 Oct; 15(10):1388-1397. PubMed ID: 28634225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]